Summary of Product Characteristics
last updated on the eMC:
08/01/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 08/01/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
-
Change to section 7 - Marketing Authorisation Holder
|
|
Updated on 10/11/2006 and displayed until 08/01/2010
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 26/09/2006 and displayed until 10/11/2006
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 6. 6 - Instruction for Use/Handling
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 26/09/2006 and displayed until 26/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 6. 6 - Instruction for Use/Handling
|
|
Updated on 26/09/2006 and displayed until 26/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 4.4 - Special Warnings and Precautions for Use
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 6. 6 - Instruction for Use/Handling
|
|
Updated on 20/09/2006 and displayed until 26/09/2006
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
-
Pending awaiting re-submission
|
|
Updated on 19/09/2006 and displayed until 20/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 11/10/2005 and displayed until 19/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 12/08/2005 and displayed until 11/10/2005
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 21/08/2001 and displayed until 12/08/2005
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 4.8 - Undesirable Effects
|
|
Updated on 06/09/1999 and displayed until 21/08/2001
|
Reasons for adding or updating:
|
|
|
|